Literature DB >> 10351934

Occupational asthma caused by isocyanates: patterns of asthmatic reactions to increasing day-to-day doses.

J L Malo1, H Ghezzo, R Elie.   

Abstract

Inhalation challenges to isocyanates are conducted in specialized centers to confirm occupational asthma. The pattern of asthmatic reactions due to consecutively increasing daily doses of isocyanates is unknown. We conducted a study involving 24 subjects who had undergone specific inhalation challenges to isocyanates (toluene diisocyanate [TDI], n = 8; hexamethylene diisocyanate [HDI], n = 10; and methylene diisocyanate [MDI], n = 6) on three or more consecutive days. Challenge tests were given through a closed-circuit apparatus (n = 12) or in small cubicles (n = 12), allowing assessment of the total inhaled dose (concentration x duration). The pattern of asthmatic reactions was described. In addition, dose-response curves were analyzed and tested for their linear and quadratic trends. Four patterns of response were observed: (1) linear (n = 10); (2) minimal effect followed by a brisk change (n = 7); (3) significant change followed by tachyphylaxis or a plateau (n = 4); (4) biphasic (i.e., significant change followed by a reduction in the effect and significant change on the last day of exposure [n = 3]). Subjects with a linear dose-response pattern had been exposed to isocyanates at work for a significantly shorter interval (7.2 +/- 6.7 yr) than subjects with a nonlinear pattern (20.0 +/- 13.1 yr). An analysis of variance covering a 3-d period for all subjects showed a significant linear model for the response (p < 0.0001); there was no quadratic trend. However, when the analysis was done on subjects with four or more days of challenge (n = 10), we found both linear and quadratic significant components. This analysis shows that the most common pattern of asthmatic reactions to inhaled isocyanates generated on consecutive days is linear; however, other patterns are also observed. In some individuals, particularly those in whom more days of challenge are required, we observed in addition to a strong linear component a quadratic component manifested by a brisk change on the last day of exposure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10351934     DOI: 10.1164/ajrccm.159.6.9806159

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  11 in total

1.  Genetic variants in TNFα, TGFB1, PTGS1 and PTGS2 genes are associated with diisocyanate-induced asthma.

Authors:  Berran Yucesoy; Michael L Kashon; Victor J Johnson; Zana L Lummus; Kara Fluharty; Denyse Gautrin; André Cartier; Louis-Philippe Boulet; Joaquin Sastre; Santiago Quirce; Susan M Tarlo; Maria-Jesus Cruz; Xavier Munoz; Michael I Luster; David I Bernstein
Journal:  J Immunotoxicol       Date:  2015-09-04       Impact factor: 3.000

2.  Genetic variants in antioxidant genes are associated with diisocyanate-induced asthma.

Authors:  Berran Yucesoy; Victor J Johnson; Zana L Lummus; Grace E Kissling; Kara Fluharty; Denyse Gautrin; Jean-Luc Malo; André Cartier; Louis-Philippe Boulet; Joaquin Sastre; Santiago Quirce; Dori R Germolec; Susan M Tarlo; Maria-Jesus Cruz; Xavier Munoz; Michael I Luster; David I Bernstein
Journal:  Toxicol Sci       Date:  2012-05-17       Impact factor: 4.849

3.  CTNNA3 (α-catenin) gene variants are associated with diisocyanate asthma: a replication study in a Caucasian worker population.

Authors:  David I Bernstein; Michael Kashon; Zana L Lummus; Victor J Johnson; Kara Fluharty; Denyse Gautrin; Jean-Luc Malo; André Cartier; Louis-Philippe Boulet; Joaquin Sastre; Santiago Quirce; Dori Germolec; Susan M Tarlo; Maria-Jesus Cruz; Xavier Munoz; Michael I Luster; Berran Yucesoy
Journal:  Toxicol Sci       Date:  2012-09-13       Impact factor: 4.849

4.  Diagnosis and prevention of diseases induced by isocyanate.

Authors:  Kazuko Nakashima; Tatsuya Takeshita; Kanehisa Morimoto
Journal:  Environ Health Prev Med       Date:  2002-05       Impact factor: 3.674

5.  Genome-Wide Association Study Identifies Novel Loci Associated With Diisocyanate-Induced Occupational Asthma.

Authors:  Berran Yucesoy; Kenneth M Kaufman; Zana L Lummus; Matthew T Weirauch; Ge Zhang; André Cartier; Louis-Philippe Boulet; Joaquin Sastre; Santiago Quirce; Susan M Tarlo; Maria-Jesus Cruz; Xavier Munoz; John B Harley; David I Bernstein
Journal:  Toxicol Sci       Date:  2015-04-26       Impact factor: 4.849

6.  Interferon-γ promoter is hypermethylated in blood DNA from workers with confirmed diisocyanate asthma.

Authors:  Bin Ouyang; David I Bernstein; Zana L Lummus; Jun Ying; Louis-Philippe Boulet; André Cartier; Denyse Gautrin; Shuk-Mei Ho
Journal:  Toxicol Sci       Date:  2013-03-27       Impact factor: 4.849

7.  N-Acetyltransferase 2 Genotypes Are Associated With Diisocyanate-Induced Asthma.

Authors:  Berran Yucesoy; Grace E Kissling; Victor J Johnson; Zana L Lummus; Denyse Gautrin; André Cartier; Louis-Philippe Boulet; Joaquin Sastre; Santiago Quirce; Susan M Tarlo; Maria-Jesus Cruz; Xavier Munoz; Michael I Luster; David I Bernstein
Journal:  J Occup Environ Med       Date:  2015-12       Impact factor: 2.162

8.  Genetic variants in the major histocompatibility complex class I and class II genes are associated with diisocyanate-induced Asthma.

Authors:  Berran Yucesoy; Victor J Johnson; Zana L Lummus; Michael L Kashon; Marepalli Rao; Hansen Bannerman-Thompson; Bonnie Frye; Wei Wang; Denyse Gautrin; André Cartier; Louis-Philippe Boulet; Joaquin Sastre; Santiago Quirce; Susan M Tarlo; Dori R Germolec; Michael I Luster; David I Bernstein
Journal:  J Occup Environ Med       Date:  2014-04       Impact factor: 2.162

Review 9.  Hazardous air pollutants and asthma.

Authors:  George D Leikauf
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

10.  Elimination kinetics of diisocyanates after specific inhalative challenges in humans: mass spectrometry analysis, as a basis for biomonitoring strategies.

Authors:  Lygia T Budnik; Dennis Nowak; Rolf Merget; Catherine Lemiere; Xaver Baur
Journal:  J Occup Med Toxicol       Date:  2011-03-29       Impact factor: 2.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.